How can polymyxin B be dosed based on current pharmacokinetic knowledge?
- PMID: 38847855
- DOI: 10.1007/s00228-024-03708-3
How can polymyxin B be dosed based on current pharmacokinetic knowledge?
References
-
- Wang X, Xiong W, Zhong M et al (2024) Pharmacokinetics of polymyxin B in different populations: a systematic review. Eur J Clin Pharmacol. https://doi.org/10.1007/s00228-024-03666-w - DOI - PubMed - PMC
-
- Wang P, Liu S, Sun T, Yang J (2024) Daily fluid intake as a novel covariate affecting the population pharmacokinetics of polymyxin B in patients with sepsis. Int J Antimicrob Agents 63:107099. https://doi.org/10.1016/j.ijantimicag.2024.107099 - DOI - PubMed
-
- Hanafin PO, Kwa A, Zavascki AP et al (2023) A population pharmacokinetic model of polymyxin B based on prospective clinical data to inform dosing in hospitalized patients. Clin Microbiol Infect 29:1174–1181. https://doi.org/10.1016/j.cmi.2023.05.018 - DOI - PubMed
-
- Liang D, Liang Z, Deng G et al (2023) Population pharmacokinetic analysis and dosing optimization of polymyxin B in critically ill patients. Front Pharmacol 14:1122310. https://doi.org/10.3389/fphar.2023.1122310 - DOI - PubMed - PMC
-
- Li X, Cheng Y, Chen B et al (2023) Population pharmacokinetics of polymyxin B in patients with liver dysfunction. Br J Clin Pharmacol 89:3561–3572. https://doi.org/10.1111/bcp.15855 - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
